Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.
about
Once-daily trospium chloride 60 mg extended release in subjects with overactive bladder syndrome who use multiple concomitant medications: Post hoc analysis of pooled data from two randomized, placebo-controlled trials.Emerging drugs for treatment of urinary incontinence.Mirabegron for the treatment of overactive bladder: a prespecified pooled efficacy analysis and pooled safety analysis of three randomised, double-blind, placebo-controlled, phase III studies.Update on the management of overactive bladder: patient considerations and adherenceTreatment of Overactive Bladder in the Elderly Female: The Case for Trospium, Oxybutynin, Fesoterodine and Darifenacin.Trospium chloride once-daily extended release is efficacious and tolerated in elderly subjects (aged ≥ 75 years) with overactive bladder syndrome.Once-daily administration of trospium chloride extended release provides 24-hr coverage of nocturnal and diurnal symptoms of overactive bladder: an integrated analysis of two phase III trials.[Trospium chloride once daily for overactive bladder syndrome: results of a multicenter observational study].Trospium chloride has no effect on memory testing and is assay undetectable in the central nervous system of older patients with overactive bladder.Antimuscarinic agents in elderly people.
P2860
Q33806201-C8355611-8261-4DA1-B027-5D959ED79F76Q34618648-F6AB069B-1204-41CD-9A4A-CB3DE28B0F54Q37119868-0F926B90-CAB6-4229-9AB7-F395802286D4Q37283704-A2890E94-A3CF-42C9-BDD6-B236CDA07C41Q38590670-DFCDE0C0-B327-4818-93D5-9AFBF1EE6EE0Q42671934-821F74A5-1419-417D-AC98-9B90F03AD54AQ43325794-66CD6FA9-CFBE-4A9A-A4C9-A43E7750F645Q43833494-3F09DF9E-EA56-4CD9-B36C-232A03FE7315Q48160047-C4519F04-09EE-4EC8-B64D-39EE3ADEC01EQ51037347-357364DB-92AF-47C2-8550-91A0327F074A
P2860
Trospium chloride once-daily extended release is effective and well tolerated for the treatment of overactive bladder syndrome: an integrated analysis of two randomised, phase III trials.
description
2009 nî lūn-bûn
@nan
2009年の論文
@ja
2009年学术文章
@wuu
2009年学术文章
@zh
2009年学术文章
@zh-cn
2009年学术文章
@zh-hans
2009年学术文章
@zh-my
2009年学术文章
@zh-sg
2009年學術文章
@yue
2009年學術文章
@zh-hant
name
Trospium chloride once-daily e ...... randomised, phase III trials.
@en
Trospium chloride once-daily e ...... randomised, phase III trials.
@nl
type
label
Trospium chloride once-daily e ...... randomised, phase III trials.
@en
Trospium chloride once-daily e ...... randomised, phase III trials.
@nl
prefLabel
Trospium chloride once-daily e ...... randomised, phase III trials.
@en
Trospium chloride once-daily e ...... randomised, phase III trials.
@nl
P2093
P1476
Trospium chloride once-daily e ...... randomised, phase III trials.
@en
P2093
D R Staskin
M T Rosenberg
N R Zinner
R R Dmochowski
P304
P356
10.1111/J.1742-1241.2009.02189.X
P577
2009-12-01T00:00:00Z